Skip to content
10-Q/A

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-21-003684

← back to feed
Filed
Jun 1, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Apr 7, 2021 3.9M sh
Capex Q2 2021 · Feb 28, 2021 $0
Capex Q2 2021 · Feb 29, 2020 $5.14K
Operating Cash Flow Q2 2021 · Feb 28, 2021 −$17.45K
Operating Cash Flow Q2 2021 · Feb 29, 2020 −$1.32K
Cash And Equivalents Q2 2021 · Feb 28, 2021 $12.18K
Cash And Equivalents Q2 2021 · Aug 31, 2020 $27.63K
Cash And Equivalents Q2 2021 · Feb 29, 2020 $3.36K
Cash And Equivalents Q2 2021 · Aug 31, 2019 $5K
Stockholders Equity Q2 2021 · Feb 28, 2021 −$4.77K
Stockholders Equity Q2 2021 · Aug 31, 2020 $23.54K
Stockholders Equity Q2 2021 · Feb 29, 2020 $119
Stockholders Equity Q2 2021 · Aug 31, 2019 $2.02K
Current Liabilities Q2 2021 · Feb 28, 2021 $19.8K
Current Liabilities Q2 2021 · Aug 31, 2020 $7.8K
Total Liabilities Q2 2021 · Feb 28, 2021 $19.8K
Total Liabilities Q2 2021 · Aug 31, 2020 $7.8K
Current Assets Q2 2021 · Feb 28, 2021 $12.18K
Current Assets Q2 2021 · Aug 31, 2020 $27.63K
Total Assets Q2 2021 · Feb 28, 2021 $15.03K
Total Assets Q2 2021 · Aug 31, 2020 $31.34K
Sga Expense Q2 2021 · Feb 28, 2021 $23.77K
Sga Expense Q2 2021 · Feb 28, 2021 $28.31K
Sga Expense Q2 2021 · Feb 29, 2020 $2.03K
Sga Expense Q2 2021 · Feb 29, 2020 $4.5K
Net Income Q2 2021 · Feb 28, 2021 −$23.77K
Net Income Q2 2021 · Feb 28, 2021 −$28.31K
Net Income Q2 2021 · Feb 29, 2020 $573
Net Income Q2 2021 · Feb 29, 2020 −$1.9K
Revenue Q2 2021 · Feb 28, 2021 $0
Revenue Q2 2021 · Feb 28, 2021 $0
Revenue Q2 2021 · Feb 29, 2020 $4K
Revenue Q2 2021 · Feb 29, 2020 $4K